|
21 Dec 2018 |
Xynomic Pharma Acquires Global Exclusive Rights to Phase 2 Ready mTORC1/2 Inhibitor from Boehringer Ingelheim
|
|
20 Dec 2018 |
Roivant Sciences and Daiichi Sankyo Enter into Broad Pipeline Partnership
|
|
20 Dec 2018 |
Merck KGaA, Darmstadt, Germany, Assigns Chimeric Antigen Receptor T-cell (CAR-T) Rights to Intrexon
|
|
20 Dec 2018 |
Pfizer and GlaxoSmithKline Announce Joint Venture to Create a Premier Global Consumer Healthcare Company
|
|
20 Dec 2018 |
Gilead and Agenus Enter Into Collaboration to Develop Immuno-Oncology Therapies
|
|
20 Dec 2018 |
Ayala Pharmaceuticals Signs Deal to Develop and Commercialize AL102 in Combination with BCMA Targeting Agents in Multiple Myeloma
|
|
20 Dec 2018 |
Tetra Discovery Partners and Shionogi & Co., Ltd. Collaborate on BPN14770 Development and Commercialization
|
|
20 Dec 2018 |
Gilead Sciences and Scholar Rock Announce Strategic Collaboration to Develop Novel Therapies for Fibrotic Diseases
|
|
20 Dec 2018 |
Akaal Pharma Pty Ltd Announces Licensing Agreement for its First-in-Class, Topical Spingosine-1-Phosphate-1 (S1P1) Receptor Modulator for Atopic Dermatitis and Psoriasis
|
|
20 Dec 2018 |
X-Chem enters strategic collaboration with Bristol-Myers Squibb
|
|
19 Dec 2018 |
Pyramid Biosciences Announces Exclusive Global License of AstraZeneca TRK Program for Dermatology and Inflammatory Diseases
|
|
19 Dec 2018 |
Kineta Enters Research Collaboration and License Agreement with Pfizer to Develop New Cancer Immunotherapies
|
|
19 Dec 2018 |
Bridge Biotherapeutics Signs US$40M License Agreement with Daewoong Pharmaceutical for Co-development of UC Drug Candidate
|
|
19 Dec 2018 |
AC Immune and WuXi Biologics to Establish an Exclusive Strategic Partnership
|
|
19 Dec 2018 |
Ligand Acquires Milestone and Royalty Rights to PTX-022 from Palvella Therapeutics
|
|
19 Dec 2018 |
Horizon Discovery Group plc enters an exclusive partnership with C4X Discovery Holdings plc to validate targets and develop next-generation oncology drugs
|
|
19 Dec 2018 |
Daiichi Sankyo Out-Licenses ROS1/NTRK Inhibitor DS-6051 to AnHeart Therapeutics
|
|
19 Dec 2018 |
Sandoz enters into commercialization and supply agreement for insulin biosimilars, anticipating growing demand as diabetes burden rises
|
|
19 Dec 2018 |
Lilly and Aduro Biotech Announce Research Collaboration and License Agreement to Develop Novel Immunotherapies
|
|
19 Dec 2018 |
Amgen And Molecular Partners Announce Strategic Collaboration In Immuno-Oncology
|
|
17 Dec 2018 |
Bristol-Myers Squibb and H3 Biomedicine Announce Research Collaboration to Advance Novel Therapeutics Leveraging H3’s RNA Splicing Platform
|
|
17 Dec 2018 |
Proteostasis Therapeutics Announces Global License Agreement with Genentech
|
|
17 Dec 2018 |
Staten Biotechnology B.V. and Novo Nordisk A/S announce collaboration to develop novel treatment for dyslipidaemia
|
|
15 Dec 2018 |
Prestige BioPharma Partners with Cipla Ltd to Market Key Cancer Biosimilar
|
|
14 Dec 2018 |
Adaptive Phage Therapeutics Enters into Collaboration Agreement with Researchers at Yale University to Manufacture and Supply Therapeutic Bacteriophage
|
